Degenerative Disc Disease Market by Product and Geography - Forecast and Analysis 2022-2026

The degenerative disc disease market share is expected to increase by USD 1.03 billion from 2021 to 2026, and the market’s growth momentum will accelerate at a CAGR of 8.51%.

This degenerative disc disease market research report provides valuable insights on the post-COVID-19 impact on the market, which will help companies evaluate their business approaches. Furthermore, this report extensively covers degenerative disc disease market segmentations by product (drugs and devices) and geography (North America, Europe, Asia, and Rest of World (ROW)). The degenerative disc disease (DDD) market report also offers information on several market vendors, including AnGes Inc., Ankasa, B. Braun SE, BIOPHARM GmbH, BioRestorative Therapies Inc., Biosplice Therapeutics Inc., Bone Therapeutics SA, CalSpine MD, Cousin Biotech, DiscGenics Inc., Globus Medical Inc., Johnson and Johnson, Medtronic Plc, Pfizer Inc., RTI Surgical Inc., Smith and Nephew plc, Ulrich Medical USA Inc., and Zimmer Biomet Holdings Inc. among others.

What will the Degenerative Disc Disease Market Size be During the Forecast Period?

Download Report Sample to Unlock the Degenerative Disc Disease Market Size for the Forecast Period and Other Important Statistics

 

Degenerative Disc Disease Market: Key Drivers, Trends, and Challenges

The growing geriatric population is notably driving the degenerative disc disease market growth, although factors such as the availability of alternative therapies may impede the market growth. Our research analysts have studied the historical data and deduced the key market drivers and the COVID-19 pandemic impact on the degenerative disc disease industry. The holistic analysis of the drivers will help in deducing end goals and refining marketing strategies to gain a competitive edge.

Key Degenerative Disc Disease Market Driver

The growing geriatric population is one of the key drivers fueling the degenerative disc disease market growth. Primarily, human intervertebral discs undergo age-related degenerative changes that contribute to some of the most common causes of impairment and disability in the older population, such as spine stiffness, neck pain, and back pain. The spine is made up of bones and intervertebral discs. With age, the discs become dry and lose their protection of the bones. Thus, the aging population is more prone to DDD, and the growing aging population globally will thus spur the demand for DDD treatment during the forecast period. 

Key Degenerative Disc Disease Market Trend

The launch of innovative products is one of the key DDD market trends propelling market growth. The technologically advanced products are more effective in the treatment of DDD compared to the available treatments. For instance, in May 2020, DePuy Synthes announced the launch of their new technology, the CONCORDE LIFT Interbody Implant. The new implantable device was designed to help treat patients suffering from DDD. This implant has been specially designed to help simplify important stages of spinal fusion surgery to help restore spinal disc height between two vertebrae. Thus, the launch of such innovative and technologically advanced products will boost the growth of the market during the forecast period.

Key Degenerative Disc Disease Market Challenge

The availability of alternative therapies is one of the factors hindering the degenerative disc disease market growth. Nowadays, with rising awareness about the side effects of medications, the majority of the population is moving toward exercise and physiotherapy. It relieves pain and increases movement and flexibility through exercise therapy, manual therapy to improve joint flexibility and muscle stiffness, posture and movement education, and pain-relieving treatments such as traction and electrical stimulation. Such physiotherapist-directed exercise therapy, healthy eating, and aerobic exercise also help to reduce body weight and, therefore, spinal load. Thus, the rising popularity of physiotherapies and other exercises for the treatment of DDD will impede the growth of the market during the forecast period.

This degenerative disc disease market analysis report also provides detailed information on other upcoming trends and challenges that will have a far-reaching effect on the market growth. The actionable insights on the trends and challenges will help companies evaluate and develop growth strategies for 2022-2026.

Parent Market Analysis

Technavio categorizes the global degenerative disc disease (DDD) market as a part of the global pharmaceuticals market. Our research report has extensively covered external factors influencing the parent market growth potential in the coming years, which will determine the levels of growth of the degenerative disc disease market during the forecast period.

Who are the Major Degenerative Disc Disease Market Vendors?

The report analyzes the market’s competitive landscape and offers information on several market vendors, including:

 

• AnGes Inc.
• Ankasa
• B. Braun SE
• BIOPHARM GmbH
• BioRestorative Therapies Inc.
• Biosplice Therapeutics Inc.
• Bone Therapeutics SA
• CalSpine MD
• Cousin Biotech
• DiscGenics Inc.
• Globus Medical Inc.
• Johnson and Johnson
• Medtronic Plc
• Pfizer Inc.
• RTI Surgical Inc.
• Smith and Nephew plc
• Ulrich Medical USA Inc.
• Zimmer Biomet Holdings Inc.

 

This statistical study of the degenerative disc disease market encompasses successful business strategies deployed by the key vendors. The degenerative disc disease market is fragmented and the vendors are deploying growth strategies such as pricing, R&D, quality, geographical coverage, product offerings, and the development of technologically advanced products to compete in the market.

Product Insights and News

• AGRO Merchants Group - Through the value added services segment, the company offers repacking services, blast and plate freezing, and inspection services. 
• AGRO Merchants Group  - The company offers cold chain logistic solutions with temperature-controlled warehousing and handling solutions that include manual, semi-automated, and fully automated processes such as layer picking, voice picking, etc. 

To make the most of the opportunities and recover from the post-COVID-19 impact, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.

The degenerative disc disease market forecast report offers in-depth insights into key vendor profiles. The profiles include information on the production, sustainability, and prospects of the leading companies.

Degenerative Disc Disease Market Value Chain Analysis

Our report provides extensive information on the value chain analysis for the degenerative disc disease market, which vendors can leverage to gain a competitive advantage during the forecast period. The end-to-end understanding of the value chain is essential in profit margin optimization and evaluation of business strategies. The data available in our value chain analysis segment can help vendors drive costs and enhance customer services during the forecast period.

Which are the Key Regions for Degenerative Disc Disease Market?

For more insights on the market share of various regions Request PDF Sample now!

42% of the market’s growth will originate from North America during the forecast period. The US is the key market for the degenerative disc disease market in North America. Market growth in this region will be slower than the growth of the market in Asia.

The rising geriatric population will facilitate the degenerative disc disease market growth in North America over the forecast period. This market research report entails detailed information on the competitive intelligence, marketing gaps, and regional opportunities in store for vendors, which will assist in creating efficient business plans.

COVID Impact and Recovery Analysis

 The regional market growth declined in 2020 due to the outbreak of COVID-29. However, large-scale vaccination drives, the adoption of telehealth, and the lifting of stay-at-home policies regained market revenue in the region in the first half of 2021. In addition, returning to normalcy and fastened research programs for DDD treatment are expected to drive the growth of the market during the forecast period.

What are the Revenue-generating Product Segments in the Degenerative Disc Disease Market?

To gain further insights on the market contribution of various segments Request PDF Sample

The degenerative disc disease (DDD) market share growth by the drugs segment will be significant during the forecast period. The segment is expected to grow during the forecast period owing to the rising incidence of DDD among the geriatric population. Spinal disc degeneration is a normal part of aging. Between 70% and 80% of people under the age of 50 and over 90% of people over the age of 60 have degenerative disc disease. Moreover, DDD is initially treated conservatively with over-the-counter or prescription drugs and nonsteroidal anti-inflammatory drugs (NSAIDs).

This report provides an accurate prediction of the contribution of all the segments to the growth of the degenerative disc disease market size and actionable market insights on the post-COVID-19 impact on each segment.

 

Degenerative Disc Disease Market Scope
Report Coverage	Details
Page number	120
Base year	2021
Forecast period	2022-2026
Growth momentum & CAGR	Accelerate at a CAGR of 8.51%
Market growth 2022-2026	$ 1.03 billion
Market structure	Fragmented
YoY growth (%)	8.0
Regional analysis	North America, Europe, Asia, and Rest of World (ROW)
Performing market contribution	North America at 42%
Key consumer countries	US, Germany, UK, China, and Japan
Competitive landscape	Leading companies, Competitive strategies, Consumer engagement scope
Key companies profiled	AnGes Inc., Ankasa, B. Braun SE, BIOPHARM GmbH, BioRestorative Therapies Inc., Biosplice Therapeutics Inc., Bone Therapeutics SA, CalSpine MD, Cousin Biotech, DiscGenics Inc., Globus Medical Inc., Johnson and Johnson, Medtronic Plc, Pfizer Inc., RTI Surgical Inc., Smith and Nephew plc, Ulrich Medical USA Inc., and Zimmer Biomet Holdings Inc.
Market dynamics	Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, and Market condition analysis for the forecast period.
Customization purview	If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Request PDF sample

What are the Key Data Covered in this Degenerative Disc Disease Market Report?

• CAGR of the market during the forecast period 2022-2026
• Detailed information on factors that will drive degenerative disc disease market growth during the next five years
• Precise estimation of the degenerative disc disease market size and its contribution to the parent market
• Accurate predictions on upcoming trends and changes in consumer behavior
• The growth of the degenerative disc disease  industry across North America, Europe, Asia, and Rest of World (ROW)
• A thorough analysis of the market’s competitive landscape and detailed information on vendors
• Comprehensive details of factors that will challenge the growth of degenerative disc disease market vendors

We can help! Our analysts can customize this report to meet your requirements. Get in touch